Clinical Trial Update: BH4 Responsiveness in PAH Deficiency PKU Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on BH4 responsiveness in phenylketonuria patients with PAH deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• PAH Deficiency
• Phenylketonuria

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Pku Phenylketonuria, PAH Deficiency | Phase 4 | Status: UNKNOWN